BRISTOL-MYERS SQUIBB COMPANY Other Comprehensive Income (Loss), Net of Tax
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Comprehensive Income (Loss), Net of Tax of $79.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $79.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $155.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$11.00M, a 104.78% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $41.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for fiscal 2025 was -$286.00M, a 192.86% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for fiscal 2024 was $308.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for fiscal 2023 was -$265.00M.
- BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), net of tax for fiscal 2022 was -$13.00M, a 102.28% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $79.00M 10-Q · filed 2026-07-30 | $234.00M 10-Q · filed 2026-07-30 | $223.00M derived: sum of 3 quarters · filed 2026-07-30 | $264.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $155.00M 10-Q · filed 2026-04-30 | $144.00M derived: sum of 2 quarters · filed 2026-04-30 | $185.00M derived: sum of 3 quarters · filed 2026-04-30 | $55.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $30.00M derived: sum of 2 quarters · filed 2026-02-11 | -$100.00M derived: sum of 3 quarters · filed 2026-07-30 | -$286.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $41.00M 10-Q · filed 2025-10-30 | -$89.00M derived: sum of 2 quarters · filed 2026-07-30 | -$275.00M 10-Q · filed 2025-10-30 | -$44.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$130.00M 10-Q · filed 2026-07-30 | -$316.00M 10-Q · filed 2026-07-30 | -$85.00M derived: sum of 3 quarters · filed 2026-07-30 | -$97.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$185.00M 10-Q · filed 2026-04-30 | $45.00M derived: sum of 2 quarters · filed 2026-04-30 | $33.00M derived: sum of 3 quarters · filed 2026-04-30 | -$23.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $230.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $218.00M derived: sum of 2 quarters · filed 2026-02-11 | $162.00M derived: sum of 3 quarters · filed 2026-02-11 | $308.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$12.00M 10-Q · filed 2025-10-30 | -$68.00M derived: sum of 2 quarters · filed 2025-10-30 | $78.00M 10-Q · filed 2025-10-30 | -$182.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$56.00M 10-Q · filed 2025-07-31 | $90.00M 10-Q · filed 2025-07-31 | -$170.00M derived: sum of 3 quarters · filed 2026-02-11 | -$69.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $146.00M 10-Q · filed 2025-04-24 | -$114.00M derived: sum of 2 quarters · filed 2026-02-11 | -$13.00M derived: sum of 3 quarters · filed 2026-02-11 | -$32.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$260.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$159.00M derived: sum of 2 quarters · filed 2026-02-11 | -$178.00M derived: sum of 3 quarters · filed 2026-02-11 | -$265.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $101.00M 10-Q · filed 2024-10-31 | $82.00M derived: sum of 2 quarters · filed 2024-10-31 | -$5.00M 10-Q · filed 2024-10-31 | -$445.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$19.00M 10-Q · filed 2024-07-26 | -$106.00M 10-Q · filed 2024-07-26 | -$546.00M derived: sum of 3 quarters · filed 2025-02-12 | -$395.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$87.00M 10-Q · filed 2024-04-25 | -$527.00M derived: sum of 2 quarters · filed 2025-02-12 | -$376.00M derived: sum of 3 quarters · filed 2025-02-12 | -$139.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$440.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$289.00M derived: sum of 2 quarters · filed 2025-02-12 | -$52.00M derived: sum of 3 quarters · filed 2025-02-12 | -$13.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $151.00M 10-Q · filed 2023-10-26 | $388.00M derived: sum of 2 quarters · filed 2023-10-26 | $427.00M 10-Q · filed 2023-10-26 | $583.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $237.00M 10-Q · filed 2023-07-27 | $276.00M 10-Q · filed 2023-07-27 | $432.00M derived: sum of 3 quarters · filed 2024-02-13 | $526.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $39.00M 10-Q · filed 2023-04-27 | $195.00M derived: sum of 2 quarters · filed 2024-02-13 | $289.00M derived: sum of 3 quarters · filed 2024-02-13 | $315.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $156.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $250.00M derived: sum of 2 quarters · filed 2024-02-13 | $276.00M derived: sum of 3 quarters · filed 2024-02-13 | $571.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $94.00M 10-Q · filed 2022-10-26 | $120.00M derived: sum of 2 quarters · filed 2022-10-26 | $415.00M 10-Q · filed 2022-10-26 | $275.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $26.00M 10-Q · filed 2022-07-27 | $321.00M 10-Q · filed 2022-07-27 | $181.00M derived: sum of 3 quarters · filed 2023-02-14 | $38.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $295.00M 10-Q · filed 2022-04-29 | $155.00M derived: sum of 2 quarters · filed 2023-02-14 | $12.00M derived: sum of 3 quarters · filed 2023-02-14 | $5.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$140.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$283.00M derived: sum of 2 quarters · filed 2023-02-14 | -$290.00M derived: sum of 3 quarters · filed 2023-02-14 | -$319.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$143.00M 10-Q · filed 2021-10-27 | -$150.00M derived: sum of 2 quarters · filed 2021-10-27 | -$179.00M 10-Q · filed 2021-10-27 | -$236.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | -$7.00M 10-Q · filed 2021-07-28 | -$36.00M 10-Q · filed 2021-07-28 | -$93.00M derived: sum of 3 quarters · filed 2022-02-09 | $1.06B derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | -$29.00M 10-Q · filed 2021-04-29 | -$86.00M derived: sum of 2 quarters · filed 2022-02-09 | $1.07B derived: sum of 3 quarters · filed 2022-02-09 | $1.09B derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | -$57.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $1.10B derived: sum of 2 quarters · filed 2022-02-09 | $1.12B derived: sum of 3 quarters · filed 2022-02-09 | $1.24B 10-K · filed 2022-02-09 |
| 2019-09-30 | $1.16B 10-Q · filed 2020-11-05 | $1.18B derived: sum of 2 quarters · filed 2020-11-05 | $1.30B 10-Q · filed 2020-11-05 | $1.15B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $23.00M 10-Q · filed 2020-08-06 | $141.00M 10-Q · filed 2020-08-06 | -$12.00M derived: sum of 3 quarters · filed 2021-02-10 | -$4.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $118.00M 10-Q · filed 2020-05-07 | -$35.00M derived: sum of 2 quarters · filed 2021-02-10 | -$27.00M derived: sum of 3 quarters · filed 2021-02-10 | -$127.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | -$153.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$145.00M derived: sum of 2 quarters · filed 2021-02-10 | -$245.00M derived: sum of 3 quarters · filed 2021-02-10 | -$156.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $8.00M 10-Q · filed 2019-10-31 | -$92.00M derived: sum of 2 quarters · filed 2019-10-31 | -$3.00M 10-Q · filed 2019-10-31 | $129.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | -$100.00M 10-Q · filed 2019-07-25 | -$11.00M 10-Q · filed 2019-07-25 | $121.00M derived: sum of 3 quarters · filed 2020-02-24 | $167.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $89.00M 10-Q · filed 2019-04-25 | $221.00M derived: sum of 2 quarters · filed 2020-02-24 | $267.00M derived: sum of 3 quarters · filed 2020-02-24 | $214.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $132.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $178.00M derived: sum of 2 quarters · filed 2020-02-24 | $125.00M derived: sum of 3 quarters · filed 2020-02-24 | $214.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | $46.00M 10-Q · filed 2018-10-25 | -$7.00M derived: sum of 2 quarters · filed 2018-10-25 | $82.00M 10-Q · filed 2018-10-25 | $314.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | -$53.00M 10-Q · filed 2018-07-26 | $36.00M 10-Q · filed 2018-07-26 | $268.00M derived: sum of 3 quarters · filed 2019-02-25 | $337.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $89.00M 10-Q · filed 2018-04-26 | $321.00M derived: sum of 2 quarters · filed 2019-02-25 | $390.00M derived: sum of 3 quarters · filed 2019-02-25 | $279.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $232.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $301.00M derived: sum of 2 quarters · filed 2019-02-25 | $190.00M derived: sum of 3 quarters · filed 2019-02-25 | -$35.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $69.00M 10-Q · filed 2017-10-26 | -$42.00M derived: sum of 2 quarters · filed 2017-10-26 | -$267.00M 10-Q · filed 2017-10-26 | -$340.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | -$111.00M 10-Q · filed 2017-07-27 | -$336.00M 10-Q · filed 2017-07-27 | -$409.00M derived: sum of 3 quarters · filed 2018-02-13 | -$631.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | -$225.00M 10-Q · filed 2017-04-27 | -$298.00M derived: sum of 2 quarters · filed 2018-02-13 | -$520.00M derived: sum of 3 quarters · filed 2018-02-13 | -$277.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | -$73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$295.00M derived: sum of 2 quarters · filed 2018-02-13 | -$52.00M derived: sum of 3 quarters · filed 2018-02-13 | -$43.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | -$222.00M 10-Q · filed 2016-10-27 | $21.00M derived: sum of 2 quarters · filed 2016-10-27 | $30.00M 10-Q · filed 2016-10-27 | $210.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $243.00M 10-Q · filed 2016-07-28 | $252.00M 10-Q · filed 2016-07-28 | $432.00M derived: sum of 3 quarters · filed 2017-02-21 | $52.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $9.00M 10-Q · filed 2016-04-28 | $189.00M derived: sum of 2 quarters · filed 2017-02-21 | -$191.00M derived: sum of 3 quarters · filed 2017-02-21 | -$149.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $180.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | -$200.00M derived: sum of 2 quarters · filed 2017-02-21 | -$158.00M derived: sum of 3 quarters · filed 2017-02-21 | -$284.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | -$380.00M 10-Q · filed 2015-10-27 | -$338.00M derived: sum of 2 quarters · filed 2015-10-27 | -$464.00M 10-Q · filed 2015-10-27 | -$293.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $42.00M 10-Q · filed 2015-07-23 | -$84.00M 10-Q · filed 2015-07-23 | $87.00M derived: sum of 3 quarters · filed 2016-02-12 | $295.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$126.00M 10-Q · filed 2015-04-28 | $45.00M derived: sum of 2 quarters · filed 2016-02-12 | $253.00M derived: sum of 3 quarters · filed 2016-02-12 | $864.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $379.00M derived: sum of 2 quarters · filed 2016-02-12 | $990.00M derived: sum of 3 quarters · filed 2016-02-12 | $1.06B 10-K · filed 2016-02-12 |
| 2013-09-30 | $208.00M 10-Q · filed 2014-10-24 | $819.00M derived: sum of 2 quarters · filed 2014-10-24 | $890.00M 10-Q · filed 2014-10-24 | $632.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $611.00M 10-Q · filed 2014-07-24 | $682.00M 10-Q · filed 2014-07-24 | $424.00M derived: sum of 3 quarters · filed 2015-02-13 | $447.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $71.00M 10-Q · filed 2014-04-29 | -$187.00M derived: sum of 2 quarters · filed 2015-02-13 | -$164.00M derived: sum of 3 quarters · filed 2015-02-13 | -$113.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | -$258.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$235.00M derived: sum of 2 quarters · filed 2015-02-13 | -$184.00M derived: sum of 3 quarters · filed 2015-02-13 | -$157.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | $23.00M 10-Q · filed 2013-10-23 | $74.00M derived: sum of 2 quarters · filed 2013-10-23 | $101.00M 10-Q · filed 2013-10-23 | -$662.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $51.00M 10-Q · filed 2013-07-25 | $78.00M 10-Q · filed 2013-07-25 | -$685.00M derived: sum of 3 quarters · filed 2014-02-14 | -$578.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $27.00M 10-Q · filed 2013-04-25 | -$736.00M derived: sum of 2 quarters · filed 2014-02-14 | -$629.00M derived: sum of 3 quarters · filed 2014-02-14 | |
| 2011-12-31 | -$763.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$656.00M derived: sum of 2 quarters · filed 2014-02-14 | -$674.00M 10-K · filed 2014-02-14 | |
| 2011-09-30 | $107.00M 10-Q · filed 2012-10-24 | $89.00M 10-Q · filed 2012-10-24 | ||
| 2010-12-31 | $170.00M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |